Hybrid Nanomaterials for Drug Delivery
-10%
portes grátis
Hybrid Nanomaterials for Drug Delivery
Kesharwani, Prashant; Jain, N.K.
Elsevier Science Publishing Co Inc
02/2022
406
Mole
Inglês
9780323857543
15 a 20 dias
1000
Descrição não disponível.
1. Nanostructures and their associated challenges for drug delivery
2. Characterization techniques of hybrid drug delivery systems
3. Hybrid drug nanocrystals for drug delivery
4. Hybrid nanogel systems for drug delivery
5. Polymer-lipid hybrid nanostructures for drug delivery
6. Hybrid chitosan-based drug delivery systems for drug delivery
7. Hybrid polymer-metal composites for drug delivery
8. Hybrid protein-inorganic nanoparticles for drug delivery
9. Silica based hybrid systems for drug delivery
10. Dendrimer nanohybrid systems for drug delivery
11. Bioactive hybrid nanowires for drug delivery
12. Hybrid carbon-based materials for drug delivery
13. Quantum dots hybrid systems for drug delivery
14. Strengths, limitations and regulatory aspects of hybrid drug delivery systems
15. Recent advances and future prospective of hybrid drug delivery systems
2. Characterization techniques of hybrid drug delivery systems
3. Hybrid drug nanocrystals for drug delivery
4. Hybrid nanogel systems for drug delivery
5. Polymer-lipid hybrid nanostructures for drug delivery
6. Hybrid chitosan-based drug delivery systems for drug delivery
7. Hybrid polymer-metal composites for drug delivery
8. Hybrid protein-inorganic nanoparticles for drug delivery
9. Silica based hybrid systems for drug delivery
10. Dendrimer nanohybrid systems for drug delivery
11. Bioactive hybrid nanowires for drug delivery
12. Hybrid carbon-based materials for drug delivery
13. Quantum dots hybrid systems for drug delivery
14. Strengths, limitations and regulatory aspects of hybrid drug delivery systems
15. Recent advances and future prospective of hybrid drug delivery systems
Este título pertence ao(s) assunto(s) indicados(s). Para ver outros títulos clique no assunto desejado.
Antibiotic properties; Anticancer agents; Bioavailability; Biocompatibility; Biosensor applications; Cancer; Cancer targeting; Challenges; Chemotherapeutic agents; Chitosan; Colloidal stability; Dendrimer; Diagnosis; Drug delivery; Drug delivery systems; EPR effect; FTIR; Gene delivery; HPMA; Hybrid; Hybrid carrier; Hybrid chitosan; Hybrid drug delivery; Hybrid drug delivery systems; Hybrid material; Hybrid nanocrystals; Hybrid nanogels; Hybrid nanoparticles; Hybrid polymer-metal composites; Hybrid protein-inorganic nanoparticles; Hybridization; Hydrogels; Inorganic nanocarriers; Limitation; Lipid-based nanoparticles; Multifunctional hybrid nanogel; NMR; Nano-cocrystal; Nanocarrier; Nanocrystals; Nanogels; Nanomaterials; Nanomedicine; Nanoparticle; Nanoparticles; Nanotechnology; Nanotoxicity; Nanowires; PEG; Pharmaceutical industry; Polymer; Polymer conjugates; Polymer-based nanoparticles; Polymer-lipid hybrid nanostructures; Polymeric micelles; Poorly water soluble drugs; Protein corona; Protein nanocarriers; Quantum dots; SAS; SMA; Silica; Solubility; Stimuli responses; Stimuli-responsive nanogels; Surface functionalization; Sustained release; Targeted delivery; Targeted drug delivery; Theranostics; Therapeutic; Toxicity; Vaccines
1. Nanostructures and their associated challenges for drug delivery
2. Characterization techniques of hybrid drug delivery systems
3. Hybrid drug nanocrystals for drug delivery
4. Hybrid nanogel systems for drug delivery
5. Polymer-lipid hybrid nanostructures for drug delivery
6. Hybrid chitosan-based drug delivery systems for drug delivery
7. Hybrid polymer-metal composites for drug delivery
8. Hybrid protein-inorganic nanoparticles for drug delivery
9. Silica based hybrid systems for drug delivery
10. Dendrimer nanohybrid systems for drug delivery
11. Bioactive hybrid nanowires for drug delivery
12. Hybrid carbon-based materials for drug delivery
13. Quantum dots hybrid systems for drug delivery
14. Strengths, limitations and regulatory aspects of hybrid drug delivery systems
15. Recent advances and future prospective of hybrid drug delivery systems
2. Characterization techniques of hybrid drug delivery systems
3. Hybrid drug nanocrystals for drug delivery
4. Hybrid nanogel systems for drug delivery
5. Polymer-lipid hybrid nanostructures for drug delivery
6. Hybrid chitosan-based drug delivery systems for drug delivery
7. Hybrid polymer-metal composites for drug delivery
8. Hybrid protein-inorganic nanoparticles for drug delivery
9. Silica based hybrid systems for drug delivery
10. Dendrimer nanohybrid systems for drug delivery
11. Bioactive hybrid nanowires for drug delivery
12. Hybrid carbon-based materials for drug delivery
13. Quantum dots hybrid systems for drug delivery
14. Strengths, limitations and regulatory aspects of hybrid drug delivery systems
15. Recent advances and future prospective of hybrid drug delivery systems
Este título pertence ao(s) assunto(s) indicados(s). Para ver outros títulos clique no assunto desejado.
Antibiotic properties; Anticancer agents; Bioavailability; Biocompatibility; Biosensor applications; Cancer; Cancer targeting; Challenges; Chemotherapeutic agents; Chitosan; Colloidal stability; Dendrimer; Diagnosis; Drug delivery; Drug delivery systems; EPR effect; FTIR; Gene delivery; HPMA; Hybrid; Hybrid carrier; Hybrid chitosan; Hybrid drug delivery; Hybrid drug delivery systems; Hybrid material; Hybrid nanocrystals; Hybrid nanogels; Hybrid nanoparticles; Hybrid polymer-metal composites; Hybrid protein-inorganic nanoparticles; Hybridization; Hydrogels; Inorganic nanocarriers; Limitation; Lipid-based nanoparticles; Multifunctional hybrid nanogel; NMR; Nano-cocrystal; Nanocarrier; Nanocrystals; Nanogels; Nanomaterials; Nanomedicine; Nanoparticle; Nanoparticles; Nanotechnology; Nanotoxicity; Nanowires; PEG; Pharmaceutical industry; Polymer; Polymer conjugates; Polymer-based nanoparticles; Polymer-lipid hybrid nanostructures; Polymeric micelles; Poorly water soluble drugs; Protein corona; Protein nanocarriers; Quantum dots; SAS; SMA; Silica; Solubility; Stimuli responses; Stimuli-responsive nanogels; Surface functionalization; Sustained release; Targeted delivery; Targeted drug delivery; Theranostics; Therapeutic; Toxicity; Vaccines
